{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:37:17Z","timestamp":1783535837350,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1038\/s41375-020-0957-z","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T14:03:59Z","timestamp":1594044239000},"page":"2279-2284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Is cancer latency an outdated concept? Lessons from chronic myeloid leukemia"],"prefix":"10.1038","volume":"34","author":[{"given":"Manuel","family":"Abecasis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5481-2555","authenticated-orcid":false,"given":"Nicholas C. P.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelina","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuko","family":"Hijiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joannah","family":"Score","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9156-1676","authenticated-orcid":false,"given":"Robert Peter","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"key":"957_CR1","doi-asserted-by":"publisher","unstructured":"Nadler DL, Zurbenko IG. Developing a Weibull Model extension to estimate cancer latency. Int Sch Res Notices. 2013:Article ID: 750857. https:\/\/doi.org\/10.5402\/2013\/750857.","DOI":"10.5402\/2013\/750857"},{"key":"957_CR2","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/leu.2017.181","volume":"31","author":"R Bejar","year":"2017","unstructured":"Bejar R. CHIP, ICUS, CCUS and other four-letter words. Leukemia. 2017;31:1869\u201371.","journal-title":"Leukemia"},{"key":"957_CR3","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.3390\/ijerph9072444","volume":"9","author":"S Ezoe","year":"2012","unstructured":"Ezoe S. Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor. Int J Environ Res Public Health. 2012;9:2444\u201353.","journal-title":"Int J Environ Res Public Health"},{"key":"957_CR4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature19823","volume":"538","author":"F Notta","year":"2016","unstructured":"Notta F, Chan-Seng-Yue M, Lemire M, Li Y, Wilson GW, Connor AA, et al. A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns. Nature. 2016;538:378\u201382.","journal-title":"Nature"},{"key":"957_CR5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0168-9525(93)90209-Z","volume":"4","author":"B Vogelstein","year":"1993","unstructured":"Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet. 1993;4:138\u201341.","journal-title":"Trends Genet"},{"key":"957_CR6","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"The Cancer Genome Atlas Research Network.","year":"2013","unstructured":"The Cancer Genome Atlas Research Network. Genomic epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368:2059\u201374.","journal-title":"N Engl J Med"},{"key":"957_CR7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature11404","volume":"489","author":"The Cancer Genome Atlas Research Network.","year":"2012","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489:519\u201325.","journal-title":"Nature"},{"key":"957_CR8","doi-asserted-by":"publisher","unstructured":"The Cancer Genome Atlas Research Network. The molecular taxonomy of primary prostate cancer. 2015. https:\/\/doi.org\/10.1016\/j.Cell.2015.10.025.","DOI":"10.1016\/j.Cell.2015.10.025"},{"key":"957_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"The Cancer Genome Atlas Network.","year":"2012","unstructured":"The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61\u201370.","journal-title":"Nature"},{"key":"957_CR10","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","volume":"349","author":"JM Goldman","year":"2003","unstructured":"Goldman JM, Melo JV. Chonic myeloid leukemia\u2014advances in biology and new approaches to treatment. N Engl J Med. 2003;349:1451\u201364.","journal-title":"N Engl J Med"},{"key":"957_CR11","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","volume":"247","author":"GQ Daley","year":"1990","unstructured":"Daley GQ, Van Etten RA, Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome. Science. 1990;247:824\u201330.","journal-title":"Science"},{"key":"957_CR12","first-page":"35","volume":"1","author":"O Dreazon","year":"1988","unstructured":"Dreazon O, Canaani E, Gale RP. Molecular biology of chronic myelogenous leukemia. Semin Hematol. 1988;1:35\u201348.","journal-title":"Semin Hematol"},{"key":"957_CR13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/315550a0","volume":"315","author":"E Shtivelman","year":"1985","unstructured":"Shtivelman E, Lifshitz B, Gale RP, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature. 1985;315:550\u20134.","journal-title":"Nature"},{"key":"957_CR14","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(13)62120-0","volume":"385","author":"JF Apperley","year":"2015","unstructured":"Apperley JF. Chronic myeloid leukaemia. Lancet. 2015;385:1447\u201359.","journal-title":"Lancet"},{"key":"957_CR15","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MW Deininger","year":"2000","unstructured":"Deininger MW, Goldman JM, Melo V. The molecular biology of chronic myeloid leukemia. Blood. 2000;96:3343\u201356.","journal-title":"Blood"},{"key":"957_CR16","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1182\/blood.V92.9.3362","volume":"92","author":"S Bose","year":"1998","unstructured":"Bose S, Deininger M, Gora-Tybor J, Goldman JM, Melo JV. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood. 1998;92:3362\u20137.","journal-title":"Blood"},{"key":"957_CR17","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1182\/blood.V86.8.3118.3118","volume":"86","author":"C Biernaux","year":"1995","unstructured":"Biernaux C, Loos M, Sels A, Hues G, Stryckmans P. Detection of major Bcr-Abl gene expression at a very love lewel in blood cells of some healthy individuals. Blood. 1995;86:3118\u201322.","journal-title":"Blood."},{"key":"957_CR18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000501146","volume":"143","author":"JW Kuan","year":"2020","unstructured":"Kuan JW, Su AT, Leong CF, Osato M, Sahida G. Systematic reciew of normal subjects harboring BCR-ABL1 fusion gene. Acta Haematol. 2020;143:96\u2013111.","journal-title":"Acta Haematol"},{"key":"957_CR19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1182\/blood.V58.1.158.158","volume":"58","author":"PJ Fialkow","year":"1982","unstructured":"Fialkow PJ, Martin PJ, Najfeld V. Evidence of a multi-step pathogenesis of chronic myelogenous leukemia. Blood. 1982;58:158\u201363.","journal-title":"Blood"},{"key":"957_CR20","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1038\/leu.2014.272","volume":"28","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Rinke J, Sch\u00e4fer V, Schnittger S, Kohlman A, Obstfelder E. et al. Molecular-definded clonal evolution in patients with chronic myeloid leukemia independent of teh BCR-ABL status. Leukemia. 2014;28:2292\u20139.","journal-title":"Leukemia"},{"key":"957_CR21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1667\/RR2892.1","volume":"179","author":"WL Hsu","year":"2013","unstructured":"Hsu WL, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodoma K, et al. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950\u20132001. Radiat Res. 2013;179:361\u201382.","journal-title":"Radiat Res"},{"key":"957_CR22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01834384","volume":"70","author":"A Corso","year":"1995","unstructured":"Corso A, Lazzarino M, Morra E, Merante S, Astori C, Berensconi P, et al. Chronic myelogenous leukemia and exposure to ionizing radiation\u2014a retrospective study of 443 patients. Ann Hematol. 1995;70:79\u201382.","journal-title":"Ann Hematol"},{"key":"957_CR23","doi-asserted-by":"crossref","unstructured":"Smith PG, Doll R. Mortality among patients with ankylosing spondylitis after a single treatrment course with x rays. Br Med J (Clinc Res Ed). 1982;28:449\u201360.","DOI":"10.1136\/bmj.284.6314.449"},{"key":"957_CR24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41375-019-0679-2","volume":"34","author":"ET Rinke","year":"2020","unstructured":"Rinke ET, Hagen J, Dmytrenko I, Hochhaus A, Dyagli I. Molecular-defined clonal evolution in patients with chronic myeloid leukemia who were exposed to ionizing radiation following the Chernobyl nuclear disaster. Leukemia. 2020;34:645\u201350.","journal-title":"Leukemia"},{"issue":"Suppl 1","key":"957_CR25","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1182\/blood-2018-99-112905","volume":"132","author":"AM Gunes","year":"2018","unstructured":"Gunes AM, Millot F, Kalwak K, Lausen B, Sedlacek P, Verslujis B, et al. Features and outcome of chronic myeloid leukemia (CML) at very young age: data from the International Pediatric CML Registry (I-CML-Ped Study). Blood. 2018;132(Suppl 1):1748.","journal-title":"Blood"},{"key":"957_CR26","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/leu.2010.174","volume":"24","author":"J Score","year":"2010","unstructured":"Score J, Calasanz MJ, Ottman O, Pane F, Yeh RF, Sobrinho-Sim\u00f5es MA, et al. Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formation. Leukemia. 2010;24:1742\u201350.","journal-title":"Leukemia"},{"key":"957_CR27","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1016\/S2352-3026(18)30173-X","volume":"5","author":"A Biondi","year":"2018","unstructured":"Biondi A, Gandemer V, De Lorenzo P. Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial. The Lancet Hematol. 2018;5:e641\u201352.","journal-title":"The Lancet Hematol"},{"key":"957_CR28","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood-2015-06-648667","volume":"127","author":"N Hijiya","year":"2016","unstructured":"Hijiya N, Schultz KR, Metzler M, Millot F, Suttorp M. Pediatric chronic myeloid leukemia is a unique disease that requires a different approach. Blood. 2016;127:392\u20139.","journal-title":"Blood"},{"key":"957_CR29","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1182\/blood-2017-06-743252","volume":"130","author":"SK Tasian","year":"2017","unstructured":"Tasian SK, Lohl ML, Hunger SP. Philadelphia chromosome-like acute lymphoblastic leukemia. Blood. 2017;130:2064\u201372.","journal-title":"Blood"},{"key":"957_CR30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.anndiagpath.2015.12.004","volume":"21","author":"L Aye","year":"2016","unstructured":"Aye L, Loghavi S, Yound KH, Siddiq I, Yin CC, Routhort MJ, et al. Preleukemic phase of chronic myelogenous leukemia: morphilogic and immunohistochemical characterization of 7 cases. Ann Diagn Pathol. 2016;21:53\u20138.","journal-title":"Ann Diagn Pathol"},{"key":"957_CR31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.yexmp.2007.08.006","volume":"83","author":"SD Hudnall","year":"2007","unstructured":"Hudnall SD, Northup J, Panova N, Suleman K, Velagaleti G. Prolonged preleukemic phase of chronic myelogenous leukemia. Exp Mol Pathol. 2007;83:484\u20139.","journal-title":"Exp Mol Pathol"},{"key":"957_CR32","first-page":"12","volume":"4","author":"JM Bennett","year":"2014","unstructured":"Bennett JM, Dsouza KG, Patel M, O\u2019Dwyer K. \u201cPreleukemic or smoldering\u201d chronic myelogenous leukemia (CML): BCR-ABL1 positive: a brief case resport. Leuk Res Rep. 2014;4:12\u20134.","journal-title":"Leuk Res Rep"},{"key":"957_CR33","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/sj.leu.2402912","volume":"17","author":"B Clarkson","year":"2003","unstructured":"Clarkson B, Strife A, Wisniewski D, Lambek CL, Liu C. Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies. Leukemia. 2003;17:1211\u201362.","journal-title":"Leukemia"},{"key":"957_CR34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11899-019-00555-3","volume":"14","author":"RP Gale","year":"2019","unstructured":"Gale RP, Apperley J. What does chronic myeloid leukaemia tell us about other leukaemias? Curr Hematol Malig Rep. 2019;14:477\u20139.","journal-title":"Curr Hematol Malig Rep"},{"key":"957_CR35","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzer KW. Cancer genome landscapes. Science. 2013;339:1546\u201358.","journal-title":"Science"},{"key":"957_CR36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMoa1412098","volume":"372","author":"CA Ortman","year":"2015","unstructured":"Ortman CA, Kent DG, Nagalia J, Silber Y, Wedge DC, Grinfield J, et al. Effect of mutation order on myeloproliferative neoplasms. N Engl J Med. 2015;372:601\u201312.","journal-title":"N Engl J Med"},{"key":"957_CR37","doi-asserted-by":"crossref","first-page":"a027060","DOI":"10.1101\/cshperspect.a027060","volume":"7","author":"DG Kent","year":"2017","unstructured":"Kent DG, Green AR. Order matters: the order of somatic mutations infucences cancer evolution. Cold Spring Harbor Perspect Med. 2017;7:a027060.","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"957_CR38","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0022-3468(90)90218-X","volume":"25","author":"JL Grasveld","year":"1990","unstructured":"Grasveld JL, Vana DW, Rscoruia FJ, McGuire W, West KW. Pancreatic tumors in children: analysis of 13 cases. J Pediatr Surg. 1990;25:1057\u201362.","journal-title":"J Pediatr Surg"},{"key":"957_CR39","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jpedsurg.2010.02.070","volume":"45","author":"DC Yu","year":"2010","unstructured":"Yu DC, Grabowski MJ, Kozakewich HP, Perez-Atayde AR, Voss SD, Shamberger RC, et al. Primary lung tumors in children and adolescents: a 90-year experience. Pediatr Surg. 2010;45:1090\u20135.","journal-title":"Pediatr Surg"},{"key":"957_CR40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/359021a0","volume":"359","author":"VS Kazakov","year":"1992","unstructured":"Kazakov VS, Demidchik EP, Astakhova LN. Thyroid cancer after Chernobyl. Nature. 1992;359:21.","journal-title":"Nature"},{"key":"957_CR41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/359021b0","volume":"359","author":"K Baverstock","year":"1992","unstructured":"Baverstock K, Egloff B, Pinchera A, Ruchti C, Williams D. Thyroid cancer after Chernobyl. Nature. 1992;359:21\u20132.","journal-title":"Nature"},{"key":"957_CR42","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1182\/blood-2002-12-3817","volume":"102","author":"MF Greaves","year":"2003","unstructured":"Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: lessons in natural history. Blood. 2003;102:2321\u201333.","journal-title":"Blood"},{"key":"957_CR43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41568-018-0015-6","volume":"18","author":"M Greaves","year":"2018","unstructured":"Greaves M. A causal mechanism for childhood acute lymphoblastic leukaemia. Nat Rev Cancer. 2018;18:471\u201384.","journal-title":"Nat Rev Cancer"},{"key":"957_CR44","doi-asserted-by":"crossref","first-page":"13950","DOI":"10.1073\/pnas.94.25.13950","volume":"94","author":"KB Gale","year":"1997","unstructured":"Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB, et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA. 1997;94:13950\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"957_CR45","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1182\/blood-2011-07-366542","volume":"118","author":"G Cazzaniga","year":"2011","unstructured":"Cazzaniga G, van Delft FW, Nigro LL, Ford AM, Score J, Iacobucci I, et al. Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph+ acute lymphoblastic leukemia. Blood. 2011;118:5559\u201365.","journal-title":"Blood"},{"key":"957_CR46","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/leu.2014.322","volume":"29","author":"D Alpar","year":"2015","unstructured":"Alpar D, Wren D, Ermini L, Mansur MB, van Delft FW, Bateman CM, et al. Clonal origins of ETV6-RUNX1+ acute lymphoblastic leukemia: studies in monozygotic twins. Leukemia. 2015;29:839\u201346.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-020-0957-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-020-0957-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-020-0957-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:41:32Z","timestamp":1684618892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-0957-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["957"],"URL":"https:\/\/doi.org\/10.1038\/s41375-020-0957-z","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,6]]},"assertion":[{"value":"6 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"NH and NCPC are consultants for Novartis and Incyte.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}